- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02196948
Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy
December 2, 2014 updated by: César Fernández-de-las-Peñas, Universidad Rey Juan Carlos
Electrolysis Percutaneous Therapeutic (EPTE) for the Management of Supraspinatus Tendinopathy
Therapeutic management of supraspinatus tendinopathy is conflicting.
There is evidence that eccentric exercise protocols can be effective for this condition.
The inclusion of other therapeutic modalities could help to the management of these patients.
A new therapeutic approach, called Electrolysis Percutaneous Therapeutic (EPTE) has been clinically developed.
The objective of this randomized clinical trial is to determine the effectiveness of the inclusion of EPTE into a eccentric exercise protocol for the management of patients with unilateral supraspinatus tendinopathy
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Madrid
-
Alcorcon, Madrid, Spain, 28922
- Universidad Rey Juan Carlos
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Unilateral supraspinatus tendinopathy
- Shoulder pain from at least 3 months
- Shoulder pain of more than 4 points on a NPRS
- Positive findings of supraspinatus tendinopathy on MRI
Exclusion Criteria:
- bilateral shoulder symptoms
- younger than 18 or older than 65 years
- history of shoulder fractures or dislocation
- cervical radiculopathy
- previous interventions with steroid injections
- fibromyalgia syndrome
- previous history of shoulder or neck surgery
- any type of intervention for the neck-shoulder area during the previous year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Electrolysis Percutaneous Therapeutic (EPTE)
Electrolysis Percutaneous Therapeutic (EPTE) consists of the application of a galvanic electrical current with an acupuncture needle in the soft tissue, in this case the supraspinatus tendon, to initiate a local inflammatory process allowing phagocytosis and repair of the affected tissue.
The technique is pain-free since the electrical intensity is adapted to each patient.
In addition, patients will be asked to perform an eccentric loading exercise program for the shoulder musculature, particularly the supraspinatus and infraspinatus muscles, to be performed on an individual basis twice every day.
The therapeutic protocol will be applied for 4 weeks.
|
|
Experimental: Eccentric exercise
Patients will be asked to perform an eccentric loading exercise program for the shoulder musculature, particularly the supraspinatus and infraspinatus muscles, to be performed on an individual basis twice every day.
The therapeutic protocol will be applied for 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in pain intensity before and after the intervention
Time Frame: Baseline, after 2 weeks of treatment and one week after the last session
|
A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patients' current level of shoulder pain, and the worst and lowest level of pain experienced in the preceding week in the shoulder area.
|
Baseline, after 2 weeks of treatment and one week after the last session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in disability before and after the intervention
Time Frame: Baseline, after 2 weeks of treatment and one week after the last session
|
The Disabilities of the Arm, Shoulder and Hand (DASH) will be used to determine the disability induced by shoulder pain
|
Baseline, after 2 weeks of treatment and one week after the last session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jose Luis Arias Buría, PT, MSc, Hospital Universitario Gregorio Marañón-Universidad Rey Juan Carlos
- Principal Investigator: César Fernández de las Peñas, PT, PhD, Universidad Rey Juan Carlos
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
July 19, 2014
First Submitted That Met QC Criteria
July 21, 2014
First Posted (Estimate)
July 22, 2014
Study Record Updates
Last Update Posted (Estimate)
December 3, 2014
Last Update Submitted That Met QC Criteria
December 2, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- URJC 22/2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Supraspinatus Tendinopathy
-
Mansoura UniversityUnknown
-
University of CadizRocío Martín Valero; Jorge Manuel Góngora Rodriguez; Manuel Rodriguez Huguet; Pablo...CompletedSupraspinatus TendinitisSpain
-
University of CadizCompleted
-
University of CadizCompleted
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedSupraspinatus TendinitisItaly
-
University of Roma La SapienzaCompletedSupraspinatus Calcifying Tendonitis
-
Riphah International UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Christian CandrianClinical Trial Unit Ente Ospedaliero CantonaleCompletedSupraspinatus InjurySwitzerland
-
University of MalayaCompletedRotator Cuff Tendinosis | PRP | Supraspinatus StrainMalaysia
Clinical Trials on Eccentric exercise
-
University of MalagaUnknownRotator Cuff Tendinopathy
-
Oslo University HospitalUniversity of OsloCompleted
-
Queen Margaret UniversityUnknownTendinopathy | Achilles TendonUnited Kingdom
-
Universidad Europea de MadridCompletedAchilles Tendinopathy | Diastasis RectiSpain
-
Utah State UniversityNot yet recruitingBlood Flow Restriction
-
Universidad Europea de MadridCompletedTendinopathy | Achilles TendonSpain
-
New York Institute of TechnologyRecruitingHypermobility SyndromeUnited States
-
Centre Hospitalier Universitaire de BesanconUnknownVentilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD (CONvEX)Chronic Obstructive Pulmonary Disease SevereFrance
-
University Hospital, Clermont-FerrandUnknown
-
Uppsala UniversityThe Swedish Research Council; Uppsala County Council, Sweden; Amersham FoundationCompleted